title: PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC.
abstract: Increased expression of PDGF-beta receptors is a landmark of hepatic stellate cell activation and transdifferentiation into myofibroblasts. However, the molecular mechanisms that regulate the fate of the receptor are lacking. Recent studies suggested that N-acetylcysteine enhances the extracellular degradation of PDGF-beta receptor by cathepsin B, thus suggesting that the absence of PDGF-beta receptors in quiescent cells is due to an active process of elimination and not to a lack of expression. In this communication we investigated further molecular mechanisms involved in PDGF-beta receptor elimination and reappearance after incubation with PDGF-BB. We showed that in culture-activated hepatic stellate cells there is no internal protein pool of receptor, that the protein is maximally phosphorylated by 5 min and completely degraded after 1 h by a lysosomal-dependent mechanism. Inhibition of receptor autophosphorylation by tyrphostin 1296 prevented its degradation, but several proteasomal inhibitors had no effect. We also showed that receptor reappearance is time and dose dependent, being more delayed in cells treated with 50 ng/ml (48 h) compared with 10 ng/ml (24 h).
authors.affiliation: Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York, USA.
authors.forename: Carmen G
authors.initials: CG
authors.lastname: Lechuga
authors.forename: Zamira H
authors.initials: ZH
authors.lastname: Hernández-Nazara
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Hernández
authors.forename: Marcia
authors.initials: M
authors.lastname: Bustamante
authors.forename: Gregory
authors.initials: G
authors.lastname: Desierto
authors.forename: Adam
authors.initials: A
authors.lastname: Cotty
authors.forename: Nachiket
authors.initials: N
authors.lastname: Dharker
authors.forename: Moran
authors.initials: M
authors.lastname: Choe
authors.forename: Marcos
authors.initials: M
authors.lastname: Rojkind
mesh_terms: D000818:Animals; D000077214:Becaplermin; D002478:Cells, Cultured; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D010982:Platelet-Derived Growth Factor / Q000008:administration & dosage*; D020574:Proto-Oncogene Proteins c-sis; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000378:metabolism*; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology
chemical_list: D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D000077214:Becaplermin; D019869:Phosphatidylinositol 3-Kinases; D020797:Receptor, Platelet-Derived Growth Factor beta